Cansortium Inc. (CNTMF)
Cansortium Inc.
5540 West Executive Drive
Suite 100
Tampa, FL 33609
United States
305-902-2720
https://getfluent.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. William M. Smith | Executive Chairman | 200k | N/D | N/D |
| Mr. Robert Beasley | CEO & Director | 560k | N/D | N/D |
| Ms. Patricia Fonseca | Chief Financial Officer | 236.11k | N/D | N/D |
| Ms. Samantha Senne Hymes | Executive Vice President of Operations | 213.85k | N/D | N/D |
| Mr. Victor Bindi | Director of Sales | 203.85k | N/D | N/D |
| Ms. Liora Boudin | Corporate Controller | 142.31k | N/D | N/D |
| Dr. Jennifer McCafferty-Fernandez | Chief Science Officer | N/D | N/D | N/D |
| Mr. Jeffrey Reath | Consultant | 197.9k | N/D | N/D |
Descripción
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Tampa, Florida.
Gestión corporativa
La calificación ISS Governance QuickScore de Cansortium Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
